Altogether, the aforementioned studies showed that TRIM31 was upregulated in liver, gastric, pancreatic, gallbladder, colorectal tumors and glioma, and higher levels of TRIM31 are related to the poor prognosis of cancer patients. This evidence concerns the gene TRIM31 and colorectal neoplasm.